Is CorMedix Inc. (CRMD) a Buy, Sell, or Hold?
NASDAQ : CRMD
CorMedix Inc. — Institutional Ownership
$7.53 USD
$0.04 (0.53%)
- Volume
- 621.2K
- Average Volume
- 1.31M
- Market Capitalization
- $590.74M
- P/E Ratio
- 3.16
- Dividend Yield
- 0.00%
- Price Target
- $13.50
- Year High
- $14.96
- Year Low
- $6.13
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.98
Institutional Ownership Summary
Institutional Ownership %
2.62%
Investors Holding
36
change: -164 | last: 200
Increased Positions
15
change: -90 | last: 105
Reduced Positions
9
change: -49 | last: 58
New Positions
5
change: -41 | last: 46
Sold Positions
162
change: 107 | last: 55
Total Calls
-
Total Puts
126.4K
Put-Call Ratio
0.00
change: -111.302 | last: 1.113
Total Invested
16.32M
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-06-12 | SHAIBATALHAMD AYMEN ABDALKADER | 4.62M | 5.90% |
| 2026-06-12 | SHAIBATALHAMD AYMEN ABDALKADER | 4.62M | 5.90% |
| 2026-05-15 | Deep Track Capital, LP | 6.27M | 7.94% |
| 2026-03-26 | The Vanguard Group | - | 0.00% |
| 2026-01-02 | SHAIBATALHAMD AYMEN ABDALKADER | 4.6M | 5.80% |
| 2025-12-01 | Deep Track Capital, LP | 4.96M | 6.29% |
| 2025-09-12 | CorMedix Inc. | 9.09M | 19.95% |
| 2025-08-08 | SHAIBATALHAMD AYMEN ABDALKADER | 4.65M | 6.20% |
| 2025-05-12 | SHAIBATALHAMD AYMEN ABDALKADER | - | 0.00% |
| 2025-04-04 | SHAIBATALHAMD AYMEN ABDALKADER | 3.54M | 5.40% |
| 2025-02-05 | BlackRock, Inc. | 4.57M | 7.50% |
| 2024-02-13 | The Vanguard Group - 23-1945930 | 2.83M | 5.15% |
| 2024-01-29 | (1) BlackRock, Inc. | 3.51M | 6.40% |
| 2022-07-08 | (1) BlackRock, Inc. | 637.78K | 1.60% |
| 2022-02-14 | Nomura Holdings, Inc. | 2M | 5.30% |
| 2022-02-14 | Nomura Global Financial Products, Inc. | 2M | 5.30% |
| 2022-02-03 | (1) BlackRock, Inc. | 2.5M | 6.60% |
| 2021-02-11 | Elliott Investment Management L.P. | 7.14M | 4.99% |
| 2021-01-29 | (1) BlackRock, Inc. | 2M | 6.20% |
| 2020-08-10 | Elliott Investment Management L.P. | 1.76M | 5.80% |
| 2020-02-07 | (1) BlackRock, Inc. | 1.71M | 6.70% |
| 2019-09-10 | Elliott International, L.P. | 4.12M | 4.99% |
| 2019-09-10 | Elliott International Capital Advisors Inc. | 4.12M | 4.99% |
| 2019-09-10 | Elliott Associates, L.P. | 2.66M | 4.99% |
| 2018-02-09 | CVI Investments, Inc. | 2.85M | 4.10% |
| 2018-02-09 | Heights Capital Management, Inc. | 2.85M | 4.10% |
| 2017-05-08 | CVI Investments, Inc. | 3.8M | 6.70% |
| 2017-05-08 | Heights Capital Management, Inc. | 3.8M | 6.70% |
| 2016-03-10 | (1) BlackRock, Inc. | 1.75M | 4.90% |
| 2016-01-28 | (1) BlackRock, Inc. | 1.81M | 5.10% |
| 2015-02-13 | Kingsbrook Opportunities Master Fund LP | 1.74M | 4.90% |
| 2015-02-13 | Kingsbrook Opportunities GP LLC | 1.74M | 4.90% |
| 2015-02-13 | Kingsbrook Partners LP | 1.74M | 4.90% |
| 2015-02-13 | Ari Storch | 1.74M | 4.90% |
| 2015-02-13 | Scott Wallace | 1.74M | 4.90% |
| 2015-02-13 | Adam J. Chill | 1.74M | 4.90% |
| 2014-03-05 | Kingsbrook Opportunities Master Fund LP | 1.48M | 6.80% |
| 2012-01-17 | ICS Opportunities, Ltd. | 200K | 1.70% |
| 2012-01-17 | Millennium International Management LP | 200K | 1.70% |
| 2012-01-17 | Millennium International Management GP LLC | 200K | 1.70% |
| 2012-01-17 | Millennium Management LLC | 200K | 1.70% |
| 2012-01-17 | Israel A. Englander | 200K | 1.70% |
| 2011-03-23 | PharmaBio Development Inc. | 1.18M | 10.00% |
| 2010-12-09 | LINDSAY A. ROSENWALD, M.D. | 577.15K | 5.00% |
| 2010-05-21 | Millennium International Management LP | 600K | 5.20% |
| 2010-05-21 | Millennium Management LLC | 600K | 5.20% |
| 2010-05-21 | Israel A. Englander | 600K | 5.20% |
| 2010-05-21 | ICS Opportunities, Ltd. | 600K | 5.20% |
| 2010-05-21 | Millennium International Management GP LLC | 600K | 5.20% |
CRMD Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $11.63 | 72.03M | $837.76M | $145.82M | $148.91M | $840.84M |
| 2024-12-31 | $8.10 | 58.87M | $476.86M | $40.65M | $517.01K | $436.73M |
| 2023-12-31 | $3.76 | 50.9M | $191.4M | $43.64M | $667.63K | $148.42M |
| 2022-12-31 | $4.22 | 40.14M | $169.38M | $43.37M | $802.43K | $126.81M |
| 2021-12-31 | $4.55 | 37.61M | $171.14M | $53.32M | $923.8K | $118.75M |
| 2020-12-31 | $7.43 | 28.56M | $212.22M | $41.91M | $1.03M | $171.34M |
| 2019-12-31 | $7.28 | 24.15M | $175.83M | $16.53M | $4689 | $159.31M |
| 2018-12-31 | $6.45 | 17.82M | $114.92M | $17.62M | $6.13M | $103.42M |
| 2017-12-31 | $2.50 | 11.03M | $27.57M | $10.38M | -$ | $17.19M |
| 2016-12-31 | $7.65 | 7.59M | $58.09M | $8.06M | -$ | $50.03M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6.79 | 79.51M | $539.87M | $178.09M | $147.42M | $509.19M |
| 2025-12-31 | $11.63 | 78.84M | $916.92M | $145.82M | $148.91M | $920.01M |
| 2025-09-30 | $11.63 | 75.93M | $883.07M | $48.49M | $148.92M | $983.49M |
| 2025-06-30 | $12.32 | 67.93M | $836.87M | $159.31M | $435.24K | $678M |
| 2025-03-31 | $6.16 | 65.24M | $401.91M | $66.29M | $476.59K | $336.1M |
| 2024-12-31 | $8.10 | 61.51M | $498.22M | $40.65M | $517.01K | $458.09M |
| 2024-09-30 | $8.08 | 58.83M | $475.31M | $35.29M | $556.42K | $440.58M |
| 2024-06-30 | $4.28 | 57.62M | $246.62M | $28.54M | $594.32K | $218.67M |
| 2024-03-31 | $4.17 | 57.5M | $239.79M | $35.18M | $631.39K | $205.24M |
| 2023-12-31 | $3.76 | 57.39M | $215.8M | $43.64M | $667.63K | $172.82M |
| 2023-09-30 | $3.70 | 56.55M | $209.25M | $53.31M | $702.95K | $156.64M |
| 2023-06-30 | $3.97 | 45.37M | $180.1M | $19.79M | $736.86K | $161.05M |